Peucedanum palustre

Peucedanum palustre contains active compounds including peucedanin, furocoumarins, and flavonoids that contribute to its expectorant and anti-inflammatory effects. The furocoumarins and flavonoids are thought to reduce airway inflammation and promote mucus clearance from the respiratory tract. However, evidence for these mechanisms is limited to traditional use and preliminary research (Evidence Level C), with no robust clinical trials confirming the exact mechanism of action in humans.

Peucedanum palustre may interact with medications that increase photosensitivity or affect liver enzyme function. The furocoumarins it contains can enhance skin sensitivity to UV light, potentially increasing the risk of photosensitivity reactions when combined with photosensitizing drugs such as certain antibiotics, diuretics, and retinoids. Due to limited research on specific drug interactions, individuals taking prescription medications should consult a healthcare provider before use (Evidence Level D).

The traditional adult dosage for Peucedanum palustre is 2-4 grams of dried herb prepared as a tea, taken for respiratory conditions. This preparation has been used in European folk medicine as an expectorant. Due to limited clinical evidence (Evidence Level C), there are no standardized, clinically validated dosing recommendations. Users should follow traditional preparation methods and avoid exceeding recommended amounts. Consult a qualified herbalist or healthcare provider for personalized guidance.

Peucedanum palustre is considered unsafe during pregnancy and should be avoided. The herb contains furocoumarins, which may pose risks during pregnancy, though specific teratogenic effects have not been well-documented. Due to insufficient safety data and the potential for adverse effects, pregnant and breastfeeding women should not use this herb. This contraindication is based on traditional knowledge and theoretical concerns (Evidence Level D) rather than clinical trial data.

The primary side effect associated with Peucedanum palustre is photosensitivity, caused by its furocoumarin content. Users may experience increased skin sensitivity to sunlight, potentially leading to sunburn or skin reactions upon UV exposure. Individuals with existing photosensitivity disorders should avoid this herb. To minimize risk, avoid prolonged sun exposure while using this herb and for several days afterward. Other potential side effects are not well-documented due to limited clinical research (Evidence Level C).